Cholesterol Med Fenofibrate Might Slow Vision Loss in People With Diabetes
By Dennis Thompson HealthDay Reporter
TUESDAY, June 25, 2024 -- A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows.
Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate also can reduce the progression of diabetic retinopathy by 27% compared to placebo.
The findings were published June 21 in the journal NEJM Evidence and presented simultaneously at the American Diabetes Association’s annual meeting in Orlando, Fla.
“Diabetic retinopathy remains a leading cause of visual loss and we need simple strategies that can be widely used to reduce the progression of diabetic eye disease,” said researcher David Preiss, an associate professor at Oxford Population Health in the UK.
The results from the new trial “suggest that fenofibrate may provide a valuable addition to treat people with diabetic retinopathy,” Preiss added in a meeting news release.
Diabetic retinopathy occurs when elevated blood sugar levels damage blood vessels in the back of the eye. The vessels start to swell and leak, eventually leading to blurry vision, blank spots and blindness.
For this study, researchers recruited 1,151 adults in Scotland who had developed early diabetic retinopathy or macular degeneration. They were randomly assigned to take either fenofibrate tablets or a placebo.
Over four years, nearly 23% of people taking fenofibrate had their eye disease worsen, compared with 29% on a placebo, results show.
Fenofibrate also cut the risk of developing macular edema, which is a potentially harmful swelling in the retina.
Participants’ progress will continue to be tracked, to better understand the long-term effects of fenofibrate on health, researchers said.
Sources
- American Diabetes Association, news release, June 21, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Too Much Cinnamon May Interfere With Some Medications, Study Shows
MONDAY, May 5, 2025 — Consuming too much cinnamon might affect how your body absorbs some medications, new research shows. The study — published in the June issue of...
High Blood Pressure, Diabetes More Fatal For Men
FRIDAY, May 2, 2025 -- Men are more likely than women to die from high blood pressure, diabetes and HIV/AIDS, after shrugging off medical care for the conditions, a new study...
Umbilical Cord Could Contain Clues For Child's Future Health
FRIDAY, April 25, 2025 -- Doctors might be able to predict a newborn's long-term health outlook, by analyzing their umbilical cord blood, a new study says. Genetic clues found in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.